Cordis

Founded in 1961, Cordis has built a legacy of excellence in the medical devices sector, particularly in cardiovascular care, and has become synonymous with quality and innovation. After joining the Cardinal Health family, Cordis significantly expanded its portfolio and capabilities, allowing it to reach more patients and healthcare providers around the globe. The company's focus centers on delivering high-quality products such as stents, catheter systems, guidewires, and various vascular access devices that are essential in facilitating minimally invasive procedures. One of the pillars of Cordis's success is its commitment to innovation. The medical landscape is continuously evolving, and Cordis understands that staying ahead means investing in research and development. The company allocates significant resources to discover and create next-generation solutions that not only improve current treatments but also pave the way for new methodologies in interventional cardiology. By leveraging state-of-the-art technology and rigorous clinical testing, Cordis ensures that its products consistently meet the highest standards of safety and effectiveness. For healthcare professionals, Cordis represents reliable partnership and support. With the complexity of today’s medical procedures, the company offers a comprehensive suite of educational resources and training programs. These initiatives equip practitioners with the knowledge and skills they need to navigate advanced techniques confidently, ensuring that patients receive optimal care. By fostering collaboration and open communication with healthcare providers, Cordis creates a community focused on improving outcomes in cardiovascular health. The challenges of cardiovascular diseases are significant. They account for over 32% of all global deaths, urging a proactive approach to prevention and treatment. Cordis addresses this need by prioritizing patient-centric solutions that minimize invasiveness and enhance recovery times. The innovative design of its products not only reduces the physical and emotional toll on patients but also streamlines procedures for healthcare professionals, allowing them to deliver efficient care. Cordis firmly believes that every patient deserves access to the best treatment possible, and it continuously strives to remove barriers for successful heart health management. Furthermore, Cordis is expanding its global footprint, operating in over 90 countries and adapting its offerings to meet diverse healthcare needs. This international reach enables Cordis to understand and respond to various healthcare challenges, customizing products and strategies to suit different markets. By aligning its mission with the respective healthcare systems and practices of these regions, Cordis ensures that it plays an integral role in the broader fight against cardiovascular diseases worldwide. In summary, Cordis is not just a company that manufactures medical devices; it is a driving force in transforming cardiovascular care. By combining innovation, education, and a patient-first approach, Cordis empowers healthcare providers to deliver exceptional treatment outcomes. As the world continues to face increasing cardiovascular health challenges, Cordis remains steadfast in its mission to provide advanced, effective solutions that enhance the quality of care and improve patient lives globally. It’s a commitment that guarantees both quality and compassion in healthcare, making Cordis the partner of choice in the journey toward better heart health.

Cordis differentiates its products from competitors by focusing on several key factors: innovation, quality, and patient-centric design. While the medical device industry is crowded with various interventional cardiovascular solutions, Cordis stands out through its commitment to continuous advancement in technology and design. The company invests significantly in research and development, ensuring that its products incorporate cutting-edge technologies and materials that enhance performance. For instance, Cordis’s drug-eluting stents are engineered with advanced polymer coatings that optimize drug delivery while reducing restenosis rates, thereby improving patient outcomes compared to standard stent options. Another aspect that sets Cordis apart is its rigorous emphasis on quality and safety throughout the product development lifecycle. Each product undergoes extensive testing and clinical trials to validate its effectiveness and ensure it meets the highest regulatory standards. This dedication to quality control not only builds trust among healthcare professionals but also instills confidence in patients who rely on Cordis products for their treatment. The streamlined manufacturing processes and adherence to international quality standards ensure that every device is of the highest caliber, providing consistent reliability during critical medical procedures. Moreover, Cordis excels in providing a patient-centric approach to its product development. Understanding that medical treatments can be daunting, especially for cardiovascular patients, Cordis designs its devices to minimize invasiveness and promote quicker recovery times. For example, their innovative catheter systems are designed with user-friendly functionality and precision, enabling healthcare providers to perform procedures more efficiently. This focus on ease of use translates to improved procedural outcomes and enhances the overall experience for both patients and practitioners, distinguishing Cordis products in a highly technical field. Additionally, Cordis maintains a robust support system through education and resources tailored toward healthcare providers. By offering extensive training programs and educational materials, Cordis ensures that medical professionals are well-equipped to utilize their products effectively, ultimately leading to improved patient care. This aspect of support and collaboration fosters strong relationships with healthcare providers, further distinguishing Cordis from competitors who may primarily focus on product sales without ongoing engagement with users.

• Small Businesses (1-99)
• Mid Market (100-500)
• Enterprise (500+)